Match Document Document Title
DE20121978U1 Novel chemically modified genomic DNA sequences, useful in the characterization, classification, differentiation, grading, staging, treatment and/or diagnosis of astrocytomas or predisposition to astrocytomas  
A nucleic acid (I) comprising a sequence of at least 18 bases in length of a segment of chemically pretreated genomic DNA which has any one of the sequences of (S1)-(S120) or its complement, is...
DE20121975U1 Oligonucleotide for diagnosing and treating tumors and cancer especially gliomas, astrocytomas and oligodendromas, comprises chemically modified genomic sequences of genes associated with tumors and cancers  
A nucleic acid (I) comprising a sequence of at least 18 bases of a segment of chemically pretreated genomic DNA (II) according to one of the sequences (S1) selected from 120 sequences, and its...
DE20121964U1 New nucleic acid, useful for diagnosis and therapy of metabolic disease, solid tumor and cancers, comprises segment of chemically modified genomic sequences of genes associated with metabolism  
A nucleic acid (I) comprising a sequence at least 18 bases of a segment of the chemically pretreated DNA of genes associated with metabolism such as DUSP2 (NM 004418), EPHX2 (NM 001979), QDPR (NM...
DE20121960U1 New nucleic acid derived from chemically treated metastasis genes, useful for diagnosis of cancers by analysis of cytosine methylation, also for treatment  
Nucleic acid (I) comprising at least 18 bases from a segment of the chemically pretreated DNA (A) of genes associated with metastasis, i.e. any of 198 sequences referred to but not reproduced or...
DE10229978A1 Preparation of conjugated polyunsaturated fatty acids, useful in nutrition, cosmetics and pharmaceuticals, comprises expressing specific isomerases in eukaryotic, particularly plant, cells  
Preparation of conjugated polyunsaturated fatty acids (I), having at least two double bonds, in transgenic eukaryotic organisms comprises expressing a specific nucleic acid (II) in an organism...
DE10228785B4 Detection of toxic algae  
oligonucleotide characterized in that one of the sequences SEQ ID No.1 to 19 exhibits.
DE10228785A1 Detection of toxic algae  
The invention relates to sequence-specific capture probes for the detection of toxic algae by selective hybridization of a complementary, to be detected alga clearly characterizing the nucleic...
DE10227432A1 A process for the separation of carbohydrate carboxylic acids  
The present invention relates to a method for the separation of carboxylic acids from their carbohydrate mixture by an at least single-stage reactive extraction with an extractant system...
DE10227814A1 A process for the elimination of labile funtionellen groups of chemical compounds  
The present invention provides a method for cleavage of labile functional groups from molecules by the action of electromagnetic radiation is available, wherein the molecules are brought together...
DE10226203B4 Condensed palatinose, processes for their preparation and their use  
process for producing condensed palatinose from palatinose by Melt, Palatinose a solution of a catalytically active acidic Substance added to water, the water in the obtained mixture is present in...
DE10226203A1 Condensed palatinose and processes for their preparation  
The invention relates to a novel palatinose condensation product obtained by condensation of the disaccharide palatinose in a melt of palatinose, water and an organic acid.
DE20121979U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121977U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121974U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121973U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121972U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121971U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121970U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121969U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121965U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10325815A1 New variant DNA sequence, useful for diagnosis of e.g. defecation disorders and thyroid carcinoma, is derived from the promoter region of the human RET proto-oncogene  
DNA sequence (I) that comprises the -1 to -30 region of the 5'-untranslated region (UTR) of the human RET proto-oncogene and includes the variations A at -1 to T, C or G and/or G at -5 to T, C or...
DE10226367A1 Ganglioside mit modifizierter Acylfunktion  
Bereitgestellt wird eine Gangliosidmischung, die Ganglioside der folgenden allgemeinen Formel I: DOLLAR A (Zucker)-OCH¶2¶-CH(-NH-CO-R·1·)-CH(OH)-CH=CH-R·2·, DOLLAR A worin DOLLAR A (Zucker) für...
DE10225705A1 Banderolierung von Banknoten  
Die Erfindung betrifft einen Banderolierer für Banknoten und eine Banknotenbearbeitungsvorrichtung mit einem solchen Banderolierer. DOLLAR A Ein besonders sicheres und schnelles Banderolieren ist...
DE10225628A1 CDG-Therapie mit Mannose  
Bereitgestellt werden Mannose 1-Phosphat Derivate und diese enthaltende pharmazeutische oder diätetische Mittel zur Behandlung von Glykosylierungsstörungen und insbesondere zur Behandlung von...
DE20121968U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121967U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE20121963U1 Nucleic acids for diagnosis of diseases associated with developmental genes  
Nucleic acid of genes that are associated with the development, comprising an at least 18 base long sequence segment of the chemically pretreated DNA of one of the sequences selected from the...
DE20121961U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10224624A1 Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol  
Die Erfindung betrifft die Verwendung von 1-Phenyl-3-dimethylaminopropanverbindungen zur Herstellung eines Arzneimittels zur Behandlung von vermehrtem Harndrang bzw. Harninkontinenz sowie...
DE10223057A1 Verfahren zur Erzeugung von Polynukleotidmolekülen  
Die Erfindung betrifft Verfahren zur Erzeugung von Polynukleotidmolekülen mit veränderten Eigenschaften, wobei mindestens ein Zyklus, umfassend die folgenden Schritte durchlaufen wird: DOLLAR A...
DE10222632A1 Mikrosatellitenmarker für genetische Analysen und zur Unterscheidung von Rosen  
Mikrosatelliten aus Pflanzen der Gattung Rosa, einschließlich den isolierten Mikrosatelliten, Primern aus flankierenden Regionen der Mikrosatelliten, ein Verfahren zur Herstellung der...
DE10221004A1 Detection of oligonucleotide hybridization comprises electrochemically detecting reduction and/or oxidation of a redox-active species  
Detection of oligonucleotide hybridization comprises binding uncharged oligonucleotide molecules to a surface, contacting the surface with a solution of a redox-active species, contacting the...
DE10220799A1 Verfahren zur Herstellung von C13-Alkoholgemischen  
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung eines C¶13¶-Alkoholgemisches, das insbesondere als Vorstufe für die Herstellung von Verbindungen mit tensidischen Eigenschaften und...
DE10222858A1 Verfahren zur fermentativen Herstellung schwefelhaltiger Feinchemikalien  
Die Erfindung betrifft Verfahren zur fermentativen Herstellung von schwefelhaltigen Feinchemikalien, insbesondere L-Methionin, unter Verwendung von Bakterien, in denen eine für ein...
DE10222133A1 Verfahren zur Nukleinsäure-Extraktion und Nukleinsäure-Reinigung  
Die vorliegende Erfindung betrifft die Verwendung von multivalenten Kationen und komplexbildenden Agenzien zur Nukleinsäure-Extraktion und Nukleinsäure-Reinigung mit Trägermaterialien auf...
DE10221836A1 Attenuierung von Metapneumovirus  
Die vorliegende Erfindung betrifft einen Impfstoff gegen Mitglieder der Gattung Metapneumovirus oder RSV oder ein Virus, das eine bedeutende genetische Homologie im F-Protein zu Mitgliedern der...
DE10222494A1 Parallel recovery of RNA and protein from tissue, useful e.g. for diagnosis of tumors, by treating sample with RNAlater solution, homogenizing and separating epithelial cells  
Parallel recovery of RNA and protein comprising first treating a resected tissue sample with a preparation solution containing RNAlater (RTM) at 40-100 g/100 ml, mechanically disintegrating the...
DE10221091A1 SECM zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen  
Beschrieben wird ein Verfahren zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen, das die Schritte Bereitstellen einer modifizierten Oberfläche, wobei die Modifikation in der...
DE10220894A1 Promotoren mit veränderter Transkriptionseffizienz  
Die vorliegende Erfindung betrifft eine Desoxyribonukleinsäure (DNA), umfassend mindestens eine Promotorsequenz, die von einem Wildtyp-Promotor einer methylotrophen Hefe abgeleitet ist, deren...
DE20121966U1 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle  
A nucleic acid, (I), comprising a sequence of 18 bases, of a segment of chemically pretreated DNA (CP DNA) of genes associated with cell cycle having a sequence taken from 424 sequences (Ss) and...
DE10220188A1 New antagonists of calcitonin gene-related peptide or amylin, useful for treating or preventing e.g. migraine or inflammation, are specific binding nucleic acids  
An antagonist (I) of CGRP (calcitonin gene-related peptide), especially a nucleic acid, preferably one that binds to CGRP, is new. Independent claims are also included for: (1) antagonist (Ia) of...
DE10218554A1 Syringe for purifying liquid or isolating substances from it, especially nucleic acids or proteins from blood, plasma or urine, has filter above its inlet, on which purifying agent is placed  
Syringe (12) for purifying a liquid and/or isolating substances from it has a filter (26) positioned above its inlet/outlet (24). Purifying agent (28) is placed on the filter on the side opposite...
DE10218476A1 Medicaments, cosmetics and dermatological compositions for a wide variety of skin treatments contain lignans or their glycosides  
Cosmetic and/or dermatological compositions contain lignans (or their glycosides) in addition to conventional ingredients.
DE10217994A1 A coupling product from (sic) chemical compounds of hyperbranched polysaccharide completely catabolized in the body under control of the body enzymes useful for parenteral pharmaceutically active materials  
A coupling product from (sic) chemical compounds of (sic) hyperbranched polysaccharide, i.e. from alpha-1,4-glycoside linked anhydroglucose units with alpha-1,6-glycosidal branching anhydroglucose...
DE10216426A1 Beta-L-2'-deoxy-thymidine preparation, for use as antiviral agent, from L-arabinose in 4-stage process via new oxazolidine derivative and thymidine derivative intermediates  
Preparation of beta-L-2'-deoxy-thymidine (I) involves: (a) reacting L-arabinose with cyanamide and optionally protecting the product; (b) reacting the obtained oxazoline compound (II) with a...
DE10214395A1 Parallel sequencing of nucleic acid segments, useful for detecting single-nucleotide polymorphisms, by single-base extensions with labeled nucleotide  
Parallel sequence analysis of segments of a complete nucleic acid sequence, using sequence-specific primers, is new. Parallel sequence analysis of segments of a complete nucleic acid sequence,...
DE10212397A1 Repressor der Skelettmuskeldifferenzierung, dafür kodierende Nucleinsäure und dessen Verwendung in Diagnostik und Therapie  
Offenbart werden Polypeptidsequenzen, die in der Regulation der Skelettmuskeldifferenzierung eine Rolle spielen sowie dafür kodierende Nukleinsäuren und deren Verwendung in Diagnostik und...
DE10248451A1 Fredericamycin-Derivate  
Die Erfindung betrifft neue Fredericamycin-Derivate, Arzneimittel, die diese oder deren Salze enthalten, und die Verwendung der Fredericamycin-Derivate zur Behandlung von Erkrankungen,...
DE20303420U1 Fischer-Tropsch and corresponding Guerbet alcohol mixtures, derivatives and compositions are useful e.g. in polymer, oil, cosmetic, pharmaceutical, detergent or functional fluid containing polymer surfactant and/or hydraulic fluid  
Alcohol mixtures (I) comprising Fischer-Tropsch alcohols and derivatives comprise alcohols containing (wt.%): (a) over 20% to 80% primary alcohols with a linear aliphatic chain; (b) over 10% to...
DE10209203A1 Composition useful for preparing DNA chips comprises compound with labile functional group and a sensitizer that acts by triplet-triplet energy transfer  
Chemical composition (A) comprises a molecule (I) having a labile functional group (LFG) and a compound (II) that has a triplet state energy higher than, or very close to, that of LFG. An...